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In Brief
GM-CSF is crucial for the development of
tissue inflammation in EAE, but the
identity of the pathogenic GM-CSF-
responsive cells is unclear. By targeted
deletion of the GM-CSF receptor, Becher
and colleagues reveal that CCR2+
monocytes require GM-CSF to initiate
tissue damage, with similar mechanisms
operating in both mouse and human.
Immunity
ArticleTheCytokineGM-CSFDrivestheInflammatorySignature
of CCR2+ Monocytes and Licenses Autoimmunity
Andrew L. Croxford,1 Margit Lanzinger,1 Felix J. Hartmann,1 Bettina Schreiner,1 Florian Mair,1 Pawel Pelczar,1
Bjo¨rn E. Clausen,2 Steffen Jung,3 Melanie Greter,1 and Burkhard Becher1,*
1Institute of Experimental Immunology, University of Zu¨rich, Zu¨rich 8057, Switzerland
2Institute for Molecular Medicine, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany
3Department of Immunology, Weizmann Institute of Science, 76100 Rehovot, Israel
*Correspondence: becher@immunology.uzh.ch
http://dx.doi.org/10.1016/j.immuni.2015.08.010SUMMARY
Granulocyte-macrophage colony-stimulating factor
(GM-CSF) has emerged as a crucial cytokine
produced by auto-reactive T helper (Th) cells that
initiate tissue inflammation. Multiple cell types can
sense GM-CSF, but the identity of the pathogenic
GM-CSF-responsive cells is unclear. By using condi-
tional gene targeting, we systematically deleted the
GM-CSF receptor (Csf2rb) in specific subpopula-
tions throughout the myeloid lineages. Experimental
autoimmune encephalomyelitis (EAE) progressed
normally when either classical dendritic cells (cDCs)
or neutrophils lacked GM-CSF responsiveness. The
development of tissue-invading monocyte-derived
dendritic cells (moDCs) was also unperturbed upon
Csf2rb deletion. Instead, deletion of Csf2rb in CCR2+
Ly6Chi monocytes phenocopied the EAE resistance
seen in completeCsf2rb-deficientmice. High-dimen-
sional analysis of tissue-infiltrating moDCs revealed
that GM-CSF initiates a combination of inflammatory
mechanisms. These results indicate that GM-CSF
signaling controls a pathogenic expression signature
in CCR2+Ly6Chi monocytes and their progeny, which
was essential for tissue damage.
INTRODUCTION
Dysregulated cytokine activity is now recognized as a critical
component of auto-inflammatory disorders and their respective
preclinical models. This is highlighted by genome-wide associa-
tion studies in which cytokines and their receptors represent
important risk alleles shared among multiple autoimmune dis-
eases (Cotsapas and Hafler, 2013). Among the tissue-directed
autoimmune pathologies, multiple sclerosis (MS) affects the cen-
tral nervous system (CNS) of young adults and represents the
most common CNS inflammatory disorder. Experimental auto-
immune encephalomyelitis (EAE) serves as the common animal
model for MS and is among the most widely used T-cell-depen-
dent models to study the roles of cytokines in chronic inflamma-
tory disease. There is agreement that the cytokine interleukin-23
(IL-23) renders T helper (Th) cells pathogenic (Gyu¨lve´szi et al.,
2009; McGeachy et al., 2009). The genes expressed after IL-23502 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.receptor (IL-23R) engagement do not fall into a specific Th cell
polarization pattern, but seem to represent a unique signature al-
lowing for tissue entry and initiation of inflammation. The pro-in-
flammatory cytokine GM-CSF has non-redundant functions in
several preclinical models of autoimmune disease including
EAE (Codarri et al., 2011), and neutralization of GM-CSF is
currently being tested in clinical trials for a number of diseases
including MS (trial identifier NCT: NCT01517282) and rheuma-
toid arthritis (Burmester et al., 2011).
T cells do not respond to GM-CSF, and therefore activated Th
cells must communicate with a GM-CSF-sensitive cell type to
mediate pathology. Virtually all myeloid cells express the GM-
CSF receptor (Csf2ra and Csf2rb) (Greter et al., 2012) and repre-
sent likely candidates for the critical GM-CSF-responsive entity.
Microglia (Ponomarev et al., 2005, 2007), neutrophils (Kroenke
et al., 2010), monocytes (Ko et al., 2014), dermal CD103+ den-
dritic cells (DCs) (King et al., 2010), and CNS-invading mono-
cyte-derived DCs (moDCs) (King et al., 2009; Mildner et al.,
2009) have been implicated in disease pathogenesis with an
essential, GM-CSF-dependent role ascribed to them. When all
reports are considered, exactly why GM-CSF is required for dis-
ease development is unknown. Questions also remain as to
whether a single GM-CSF-responsive cell type is needed for
EAE development, or whether multiple cell types act in concert.
In this report, we systematically addressed these questions via
a conditional gene targeting approach.We exclude an obligatory
GM-CSF-dependent function of microglia, conventional DCs
(cDCs), and neutrophils. Instead, deletion of Csf2rb by specific
and inducible delivery of Cre recombinase to CCR2+ myeloid
cells fully phenocopied the resistance observed in Csf2rb-defi-
cient mice. Lastly, we provide a high-dimensional GM-CSF-
driven pathogenic expression signature in CNS-infiltrating
moDCs, the progeny of Ly6ChiCCR2+ monocytes, required for
the initiation of tissue inflammation. Translating our findings to
humans, we show that monocytes readily respond to GM-CSF
by eliciting a pathogenic program characterized by IL-1b expres-
sion. Therefore, the role of GM-CSF in autoimmune tissue dam-
age can be traced to one specificmyeloid cell population and the
pathological mechanisms it controls.
RESULTS
Csf2rbLacZ/LacZ and Csf2rbfl/fl Mice Allow for Conditional
and/or Inducible Targeting of Csf2rb
To unambiguously identify the GM-CSF-responsive cell type
necessary for the induction of tissue inflammation, we generated
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Figure 1. Csf2rbLacZ/LacZ Mice Lack Functional Csf2rb Expression and GM-CSF Signaling Capability
(A) Schematic for the Csf2rbLacZ knockout-first allele and its subsequent conversion to the conditional Csf2rbfl using a flp-deleter strain. After Cre-mediated
recombination, exon 4 of the Csf2rb gene is excised.
(B) Lung sections of Csf2rbLacZ/+ and Csf2rbLacZ/LacZ mice were stained with hematoxilin and eosin. Arrows indicate surfactant aggregates in the alveoli of
Csf2rbLacZ/LacZ mice. Images represent three mice from each genotype and two experiments.
(C) Frequencies of CD11chiSiglec-Fhi alveolar macrophages (pre-gated on CD45+ cells) from lung tissue of indicated genotypes are shown in the dot plots. Data
represent multiple experiments.
(D)Csf2rb+/+ (n = 15) andCsf2rbLacZ/LacZ (n = 14) mice were actively immunized withMOGp35-55 emulsified in CFA (day 0, s.c.) and pertussis toxin (days 0 and 2) to
induce EAE. The severity of clinical paralysis is plotted against time. Data shown are pooled from multiple experiments.
(E) Criss-cross BM chimeric mice were generated using the indicated host and donor genotypes. After 6 weeks, mice were actively immunized and scored for
clinical EAE (n = 5 for all groups). Data represent two similar experiments.
(F)Csf2rbLacZ mice were crossed to a flp-deleter strain to generate theCsf2rbfl allele and subsequently crossed to theR26-creERT2.R26-creERT2Csf2rbfl/fl (n = 7)
and R26-creERT2 Csf2rbfl/+ control (n = 4) mice were placed on tamoxifen chow for 3 weeks, rested for a week, and then immunized to induce EAE. Clinical EAE
scores represent two experiments with at least three mice per group.
Error bars represent ± SEM. See also Figure S1.Csf2rbLacZ transgenic mice to specifically manipulate GM-CSF
responsiveness in vivo (Figure 1A). Bone marrow (BM) cells
from Csf2rbLacZ/LacZ mice lacked detectable expression of
Csf2rbmRNA, whereas expression ofCsf2ra remained unaltered
(Figure S1A). Csf2rb is also required for IL-5 signaling and we
observed a significant reduction of IL-5-dependent eosinophils
in peripheral blood taken fromCsf2rbLacZ/LacZ mice (Figure S1B).
Loss of GM-CSF or its receptor results in the absence of termi-
nally differentiated alveolar macrophages (AMs) in the lungs of
mutant mice (Guilliams et al., 2013; Shibata et al., 2001). Pulmo-
nary alveolar proteinosis (PAP) was also clearly identifiable as
surfactant aggregates in the alveoli of Csf2rbLacZ/LacZ mice (Fig-
ure 1B). CD11c+Siglec-F+ AMs were absent in the lungs of both
Csf2rbLacZ/LacZ and Csf2rb/ mice (Figure 1C). Importantly,
Csf2rbLacZ/LacZ mice were also resistant to MOG-induced EAE
(Figure 1D). Csf2rb+/+ host mice receiving Csf2rbLacZ/LacZ bone
marrow (BM) were also resistant, showing that a critical GM-
CSF-responsive cell type is derived from the hematopoietic
compartment (Figure 1E).ImWe performed allelic conversion (Figure 1A: Flp-mediated
Csf2rbLacZ / Csf2rbfl) and crossed the resulting conditional
Csf2rbfl allele with an inducible Cre-expressing strain targeting
all cells and tissues (R26-creERT2) (Ventura et al., 2007). After
3 weeks of tamoxifen feeding, mice were immunized to induce
EAE. R26-creERT2-Csf2rbfl/fl mice were protected from EAE
compared to control littermates (Figure 1F). Thus, allelic conver-
sion fromCsf2rbLacZ/Csf2rbfl allows conditional and/or induc-
ible targeting of Csf2rb.
GM-CSF Signaling in cDCs Is Dispensable
for Autoimmunity
Numerous genes are regulated by GM-CSF signaling in cDCs
(Kc et al., 2014). Indeed, both resident and migratory DCs
derived from WT skin-draining lymph nodes (SLNs) were able
to respond to exogenous GM-CSF by phosphorylating the tran-
scription factor STAT5, in contrast to the same cells isolated
from Csf2rbLacZ/LacZ mice (Figures S1C and S1D). To analyze
the requirement of GM-CSF signaling on cDCs during EAE, wemunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc. 503
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Figure 2. cDCs Do Not Require GM-CSF to Induce EAE
(A) Single-cell suspensions were prepared from lung tissue of Csf2rbfl/fl, Itgax-cre Csf2rbfl/fl, and Csf2rbLacZ/LacZ mice. cDCs and AMs were identified by FACS
staining for CD11c and Siglec-F (pre-gated on CD45), and DCs for CD11b and CD103 (pre-gated on CD45+MHC-II+CD11c+Siglec-F). Data represent three
experiments.
(B) SLNs frommice from the indicated genotypes were harvested, mechanically disrupted, and stained for the indicated markers (pre-gated on CD11c+MHC-IIhi)
prior to a brief GM-CSF stimulation (20 ng/ml, 30 min) and intracellular staining (ICS) for pSTAT5. Frequencies of pSTAT5+ DCs are indicated in the gates and
histograms. Data represent two experiments.
(C and D) Plots show the clinical scores of Cd207-cre Csf2rbfl/fl and Itgax-cre Csf2rbfl/fl mice s.c. immunized with MOGp35-55 emulsified in CFA, both repre-
sentative of two experiments (C) or four experiments (D) with at least four mice per group.
(E) Inflamed CNS of indicated mice were harvested at peak disease and infiltrating cells were isolated and stimulated with GM-CSF before ICS for pSTAT5.
Frequencies of pSTAT5+ inflammatory moDCs (CD45hiCD11b+Ly6GCD11c+pSTAT5+) are shown in the histogram and quantified in the graph. Statistical
analysis was performed (*p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test, unpaired) and one of two independent experiments is shown.
Error bars represent ± SEM. See also Figures S1 and S2.crossed the Csf2rbfl with Cre-expressing strains targeting cDCs.
The CD11c-Cre strain (Itgax-cre) shows a spectrum of activity
across a variety of cell types, with deletion upward of 95%
achievable in cDCs (Caton et al., 2007). Both Itgax-cre Csf2rbfl/fl
and Csf2rbLacZ/LacZ mice presented with the anticipated
decrease in lung-resident CD103+ DCs and CD11c+SiglecF+
alveolar macrophages (Figure 2A), highlighting a successful tar-
geting of CD11c-expressing myeloid cells in vivo.
Skin-resident CD103+ DCs are associated with the EAE resis-
tance seen in GM-CSF-negative animals immunized in a subcu-
taneous (s.c.) manner (King et al., 2010). We therefore utilized
both Langerin-Cre (Cd207-cre) and Itgax-cre mice crossed to
the Csf2rbfl/fl mice to determine whether GM-CSF signaling on
Langerin+ DCs (CD103+ DCs and Langerhans cells [LCs]) or all
cDCs, respectively, is required for EAE induction (Caton et al.,
2007; Zahner et al., 2011). To determine the deletion efficiency
of Csf2rb in cDCs, we analyzed GM-CSF-induced phosphoryla-504 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.tion of STAT5. In Cd207-cre Csf2rbfl/fl mice, STAT5 phosphory-
lation was selectively impaired in skin-derived Langerin+ DCs
in response to GM-CSF (CD103+ DCs and LCs) (Figure 2B). In
Itgax-cre Csf2rbfl/fl mice, virtually all cDCs were rendered GM-
CSF unresponsive and failed to phosphorylate STAT5 (Fig-
ure 2B). However, both Cd207-cre Csf2rbfl/fl and Itgax-cre
Csf2rbfl/fl mice developed EAE, clearly demonstrating that GM-
CSF signaling on cDCs is not required for tissue inflammation
(Figures 2C and 2D).
Whereas cDCs populate tissues in the steady state, under in-
flammatory conditions, monocytes invade inflamed sites and
differentiate into moDCs, characterized by upregulation of
CD11c and MHC class II (MHC-II) (Serbina et al., 2003). Given
the reported activity of Itgax-cre in subsets of myeloid cells other
than cDCs (Caton et al., 2007), we isolated inflammatory infil-
trates from Itgax-cre Csf2rbfl/fl mice with EAE and assayed the
infiltrating myeloid populations and their ability to respond to
GM-CSF. We observed a significant, though modest, reduction
in the frequency of GM-CSF-responsive moDCs in Itgax-cre
Csf2rbfl/fl mice compared to controls (Figure 2E). This highlights
that Itgax-cre effectively targets the Csf2rbfl locus in cDCs, but
conferred only a partial recombination in CNS-infiltrating inflam-
matory moDCs.
CNS-Invading Neutrophils and Resident Microglia Do
Not Require GM-CSF Signaling during EAE
Neutrophils and moDCs can respond to GM-CSF. During EAE,
both cell types accumulate in the CNS, where they can rapidly
phosphorylate STAT5 in response to GM-CSF (Figure S2A).
The depletion of neutrophils was shown to abrogate clinical pro-
gression of EAE (Kroenke et al., 2010), but whether their essential
effector function is controlled by GM-CSF has not been
described. We crossed the Csf2rbfl mice to the LysM-Cre
(Lyz2-cre), which shows high deletion in neutrophils and varying
degrees of activity in Ly6Chi monocytes and macrophages at
different genomic loci (Clausen et al., 1999; Jakubzick et al.,
2008; Schreiber et al., 2013). No apparent differences were
observed in circulating neutrophils or Ly6Chi monocytes in
Lyz2-cre Csf2rbfl/fl mice, although a reduction in CD131 staining
intensity was observed on both neutrophils and total monocytes
in peripheral blood (Figure 3A). Importantly, this translated into a
marked reduction in GM-CSF sensitivity in circulating neutro-
phils (Figure 3B). However, 50% of monocytes in Lyz2-cre
Csf2rbfl/fl mice could still respond to GM-CSF in the steady state,
indicative of incomplete deletion in this population.
CD115+ monocytes can be further characterized by their
expression of Ly6C (either Ly6Chi or Ly6Clo monocytes) (Geiss-
mann et al., 2010). We immunized Lyz2-cre Csf2rbfl/fl mice and
assayed blood neutrophils and Ly6Chi and Ly6Clo monocytes
at day 7 after immunization. Despite an efficient targeting of
neutrophils, Ly6Chi monocytes largely retain their ability to
respond to GM-CSF under inflammatory conditions, indicating
poor deletion in this subset (Figure 3C). Lyz2-cre Csf2rbfl/fl
mice were susceptible to EAE and comparable myeloid infil-
trates were consistently recovered from inflamed CNS tissue
of both strains (Figure 3D). Of note, GM-CSF sensitivity of
CNS-derived neutrophils was efficiently reduced in Lyz2-cre
Csf2rbfl/fl mice, where phosphorylation of STAT5 was reduced
to background staining intensity (Figure 3E) and fully differenti-
ated moDCs were also significantly targeted (Figure 3E). How-
ever, the robust GM-CSF responsiveness seen in blood Ly6Chi
monocytes of immunized Lyz2-cre Csf2rbfl/fl mice still impli-
cated these cells and their progeny as a potential target of
GM-CSF during EAE.
Microglia are radiation resistant and are not replaced by BM-
derived cells during disease progression (Greter et al., 2005).
In addition to BM chimera experiments (Figure 1E), which
excluded microglia as a critical GM-CSF responder cell, we
formally discounted this cell type by using microglia-targeting
Cx3cr1-creERT2 and Cx3cr1-cre strains crossed to the Csf2rbfl
strain (Yona et al., 2013). Both Cx3cr1-cre Csf2rbfl/fl and tamox-
ifen-treated Cx3cr1-creERT2 Csf2rbfl/fl mice were susceptible to
EAE (Figures S2B and S2C). Interestingly, we again observed
only a partial deletion of Csf2rb in Ly6Chi monocytes, whereas
Ly6Clo monocytes of Cx3cr1-cre Csf2rbfl/fl mice showed the ex-
pected loss of GM-CSF responsiveness (Figure S2D). TakenImtogether, GM-CSF signaling on cDCs, neutrophils, andmicroglia
are not critical for the development of EAE. However, Itgax-cre
Csf2rbfl/fl, Lyz2-cre Csf2rbfl/fl, and Cx3cr1-cre Csf2rbfl/fl mice all
failed to efficiently target Csf2rb in Ly6Chi monocytes.
Csf2rb Expression in CCR2+Ly6Chi Monocytes Is Critical
for EAE Development
Numerous reports have described a crucial role for CCR2 and its
ligand, CCL2/MCP-1, during EAE progression (Gaupp et al.,
2003; Mahad and Ransohoff, 2003; Saederup et al., 2010). Given
that Ly6Chi monocytes strongly express CCR2, we generated
the Ccr2-creERT2-mKate2 strain to specifically and inducibly
target CCR2+ cell types. This mouse expresses CreERT2 and
an mKate2 fluorescent reporter under the control of the Ccr2
promoter, knocked into the 30 UTR of the murine gene Ccr2 (Fig-
ure S3A). Ccr2-creERT2 Csf2rbfl/fl mice were bred and immu-
nized before administration of tamoxifen to induce Csf2rb dele-
tion in CCR2-expressing cell types. Recombination efficiency
was enhanced by homozygosity of the Ccr2-creERT2 allele,
where tamoxifen administration targeted the Csf2rb locus in
90% of Ly6Chi monocytes in Ccr2-creERT2+/+-Csf2rbfl/fl mice
(Figure S3B). Homozygous Ccr2-creERT2+/+ mice show normal
frequencies of CCR2+Ly6Chi monocytes in peripheral blood
and EAE susceptibility was maintained when immunized along-
side Ccr2/ mice (Figures S3C and S3D).
The capacity of tissue-invading moDCs to mediate tissue
damage has recently been demonstrated (Yamasaki et al.,
2014), and we reasoned that GM-CSF licenses this pathogenic
process. Ccr2-creERT2+/+ Csf2rbfl/fl and Csf2rbfl/fl control mice
were immunized and treated with tamoxifen to delete GM-CSF
responsiveness in Ly6Chi monocytes. Ccr2-creERT2+/+ Csf2rbfl/fl
mice were fully resistant to EAE induction compared to control
mice (Figure 4A). An extensive characterization of GM-CSF-
responsive myeloid cell populations was performed on immu-
nized Ccr2-creERT2+/+ Csf2rbfl/fl mice, ranging from BM precur-
sors (macrophage and DC progenitors [MDPs] and common DC
progenitors [CDPs]) to CNS-infiltrating moDCs. No significant
reduction in STAT5 phosphorylation was observed inMDPs after
tamoxifen treatment. However, recombination at the Csf2rb lo-
cus was apparent in CDPs from immunized Ccr2-creERT2+/+
Csf2rbfl/fl mice (Figure 4B). The targeting of CDPs led us to
analyze the extent to which cDCs could potentially be targeted
with the Ccr2-creERT2 strain. 48 hr after tamoxifen administra-
tion, migratory and resident DC populations in the SLN, cDCs
in spleen, and blood-derived neutrophils all maintained the abil-
ity to respond to GM-CSF (Figures S4A–S4D). Using a fate map-
ping approach (Ccr2-creERT2-STOP-TdTomato) (Madisen et al.,
2010), we observed that 10 days after an initial tamoxifen admin-
istration, migratory and resident cDCs populations in the SLN
were indeed partially targeted using the Ccr2-creERT2 strain
(Figures S4E and S4F). Given the EAE susceptibility of Itgax-
cre Csf2rbfl/fl mice (Figure 2D) and the lack of requirement for
CD103+ DCs in EAE (Edelson et al., 2011), we conclude that
any potential long-term accumulation of targeted cDCs in
Ccr2-creERT2+/+-Csf2rbfl/fl mice did not contribute to resistance
to EAE in this strain.
Blood-derived myeloid cells from immunized Ccr2-
creERT2+/+ Csf2rbfl/fl mice were assayed for GM-CSF sensi-
tivity. Although neutrophils maintained their ability to respondmunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc. 505
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Figure 3. GM-CSF Signaling Is Not Required on moDCs and Neutrophils in the CNS to Mediate Paralysis
(A) Lysed whole blood from Lyz2-cre Csf2rbfl/fl mice was stained for CD11b, Ly6G, Ly6C, and CD131 (GM-CSFRb). CD131 staining intensity for monocytes
(CD11b+CD115+) and neutrophils (CD11b+Ly6Ghi) is shown for the indicated cell types and genotypes: Csf2rbfl/fl (black) and Lyz2-cre Csf2rbfl/fl (red). Data
represent two experiments.
(B) Leukocytes from naive Csf2rbfl/fl and Lyz2-cre Csf2rbfl/fl blood were stimulated with GM-CSF in vitro (20 ng/ml, 30 min), surface stained as indicated followed
by ICS for pSTAT5. Statistics for pSTAT5+ neutrophils (CD11b+Ly6Ghi) and monocytes (CD11b+CD115+) are shown and represent multiple experiments.
(C) Lyz2-cre Csf2rbfl/fl and Csf2rbfl/fl control mice were s.c. immunized with MOGp35-55 emulsified in CFA and Ptx on days 0 and 2. Mice were bled on day 7,
stained for CD11b, Ly6G, Ly6C, and CD115, and stimulated with GM-CSF in vitro (20 ng/ml, 30min) followed by ICS for pSTAT5. Data represent two experiments
(n = 4 for both genotypes)
(D) Csf2rbfl/fl (n = 6) and Lyz2-cre Csf2rbfl/fl (n = 5) mice were s.c. immunized (as in C). Ascending clinical paralysis was then measured against time post-im-
munization. CNS of immunized mice were harvested (day 14) and infiltrating leukocytes isolated. Whole myeloid infiltrates (CD11b+CD45hi) are shown. Clinical
scores represent five independent experiments.
(E) Total inflammatory infiltrates (defined as either Ly6Ghi neutrophils or Ly6ChiCD11c+MHC-II+ moDCs, pre-gated on CD11b+CD45hi) were stimulated with GM-
CSF (20 ng/ml, 30min). Histograms showGM-CSF-induced phosphorylation of STAT5 in response to GM-CSF. Frequencies andMFI are shown in the histogram
(black,Csf2rbfl/fl; red, Lyz2-creCsf2rbfl/fl) for indicated populations and for the indicated genotypes shown in the accompanying bar charts. Closed triangles show
unstimulatedCsf2rbfl/fl moDCs stainedwith anti-pSTAT5. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired). Two independent experiments with at least
three mice per group were performed.
Error bars represent ± SEM. See also Figures S2 and S7.to GM-CSF, a 90% reduction of pSTAT5+Ly6Chi monocytes
present in peripheral blood was observed (Figure 4C). During
EAE, active SLNs show accumulation of moDCs at the
expense of migratory and resident cDCs, where they can
respond to GM-CSF by secretion of proinflammatory factors
such as IL-1b (Figures S5A–S5C). In Itgax-cre Csf2rbfl/fl and
Lyz2-cre Csf2rbfl/fl mice, no differences were noted in the gen-
eration of moDCs or cytokine-expressing T cells in the in-
flamed SLNs (Figures S5D–S5G). We assessed the ability of
SLN moDCs from immunized Ccr2-creERT2+/+ Csf2rbfl/fl mice506 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.to respond to GM-CSF and observed a highly significant
reduction of GM-CSF-responsive moDCs in the SLNs (Fig-
ure 4D). Functionally, moDCs isolated from immunized and
tamoxifen-treated Ccr2-creERT2+/+ Csf2rbfl/fl mice failed to up-
regulate IL-1b after exposure to GM-CSF (Figure 4E). Given
that Ly6ChiMHC-IIhi moDCs represent the most robust source
of IL-1b in the inflamed LN (Figure 4F), loss of GM-CSF
signaling in moDCs therefore resulted in sub-optimal expres-
sion of IL-1b at the site of T cell priming after subcutaneous
immunization.
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Figure 4. Csf2rb Expression in Ly6ChiCCR2+ Monocytes Is Critical for EAE Induction
(A) Ccr2-creERT2+/+ Csf2rbfl/fl mice were immunized to induce EAE and treated with tamoxifen (5 mg/dose) via oral gavage on days 2 and 6. Ascending clinical
paralysis was thenmeasured against identically treated control animals of indicated genotype. Data shown represents one of three independent experimentswith
similar EAE resistance observed.
(B) On day 7 after immunization and tamoxifen treatment (as in A), BM preparations from Ccr2-creERT2+/+ Csf2rbfl/fl mice and controls were surface stained for
lineage markers (B220, CD3, Ly6G, NK1.1, CD11c, MHC-II, Ly6C, CD11b) and GM-CSF-stimulated before ICS for pSTAT5. GM-CSF responsiveness of Lin
(B220Ly6GLy6CCD11bCD11cMHC-IICD3) Flt3+CD117+ (MDPs) and LinFlt3+CD117 (CDPs) was assayed and their frequencies shown in histograms
and bar charts. Data represent two experiments.
(C) Blood (as in B) was analyzed on day 7, with the pSTAT5+ frequencies of Ly6Chi monocytes (CD11b+Ly6GCD115+Ly6Chi) and Ly6Ghi neutrophils after GM-
CSF stimulation shown in the histograms and bar charts. Data represent three similar experiments.
(D) Inflamed SLNs harvested on day 7 were analyzed for GM-CSF responsiveness. Frequencies and numbers of pSTAT5+ moDCs (Ly6ChiMHC-II+CD11c+
pSTAT5+) in the active SLNs are shown. Data represent two experiments.
(E) Ly6ChiMHC-II+CD11c+ cells isolated from Ccr2-creERT2+/+ (open circles), Ccr2-creERT2+/+ Csf2rbfl/fl (closed red circles), and Csf2rbLacZ/LacZ (closed black
circles) mice were stimulated with GM-CSF and monensin for 6 hr prior to ICS for IL-1b. Frequencies of Ly6ChiMHC-IIhiIL-1b+ cells are shown in the histograms
and bar charts. Data represent three experiments.
(F) SLNs of immunizedWTmice excised at day 7 were cultured with GM-CSF andmonensin for 6 hr prior to ICS. The distribution of IL-1b and IL-1b+ cells among
Ly6C- and MHC-II-expressing cells are shown in the FACS plot (balanced numbers of each gate displayed). Data shown represent two experiments.
Significance between groups was calculated as *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired for B–E). Open bars,Ccr2-creERT2+/+; red bars,Ccr2-
creERT2+/+ Csf2rbfl/fl. Error bars represent ± SEM. See also Figures S3–S5 and S7.Deletion of Csf2rb in CCR2+ Cells Reduces Established
CNS Inflammation
Loss of Csf2rb on CCR2-expressing cells prior to disease onset
results in abrogation of disease. We investigated whether this
same deletion would provide a useful therapeutic intervention af-
ter the mice already had established clinical disease. Ccr2-
creERT2+/+ Csf2rbfl/fl mice and controls were immunized and at
the first sign of clinical disease, tamoxifen was administered
every 48 hr. Over a 2-week period, Ccr2-creERT2+/+ Csf2rbfl/fl
mice showed a reduced severity of EAE compared to controlsIm(Figure 5A). In the inflamed CNS, neutrophils maintained GM-
CSF responsiveness, whereas Ly6Chi infiltrates showed a highly
significant reduction in GM-CSF sensitivity (Figures 5B and 5C).
Lumbar spinal cords of EAE-affected, tamoxifen-treated Ccr2-
creERT2+/+ Csf2rbfl/fl mice showed significantly less demyelin-
ation compared to controls in a Luxol Fast Blue (LFB) histological
analysis, both in terms of total area and percentage of white mat-
ter (Figure 5D). Therefore, maintained GM-CSF signaling on
CCR2+ inflammatory infiltrates is required to maintain an inflam-
matory program that sustains the chronic phase of EAE.munity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc. 507
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Figure 5. Deletion of Csf2rb in CCR2+ Cells Ameliorates Established Clinical EAE
(A) Multiple cohorts ofCcr2-creERT2+/+ (pooled n = 19) andCcr2-creERT2+/+Csf2rbfl/fl (pooled n = 21) mice were immunized to induce EAE andmonitored daily for
onset of disease. Upon first sign of disease, mice received 5mg tamoxifen via oral gavage and every 48 hr for the following 14 days (indicated as arrows). Disease
for individual mice is normalized to the day of onset and statistical difference between curves calculated by two-way ANOVA. Data are pooled from three in-
dependent experiments.
(B) CNS infiltrates from sick, tamoxifen-treated mice (as in A) were isolated, stained for CD11b, CD45, Ly6C and Ly6G surface markers prior to GM-CSF
stimulation (20 ng/ml GM-CSF, 30 min), and analyzed for GM-CSF responsiveness by pSTAT5 phosphorylation analysis.
(C) Frequencies of GM-CSF-responsive cells in the indicated gates are shown in the histograms and bar charts. Total numbers of Ly6ChipSTAT5+ cells isolated
from CNS preparations of Ccr2-creERT2+/+ (n = 3) and Ccr2-creERT2+/+ Csf2rbfl/fl (n = 3) are shown.
(D) Representative histopathological stainings and quantifications (pooled from two blinded analyses) of lumbar spinal cord sections from diseased, tamoxifen-
treated mice (n = 7 for Ccr2-creERT2+/+ [white bars], n = 9 for Ccr2-creERT2+/+ Csf2rbfl/fl [red bars], n = 3 for naive WTmice [black bars]) for myelin (LFB and PAS);
scale bars represent 400 mm in the overview images and 100 mm in the insets.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired, C and D). Error bars represent ± SEM. See also Figures S3, S4, S5, and S7.GM-CSF and IL-1 Reciprocally Enhance Inflammation
in the Inflamed CNS
The Csf2rb-mediated modulation of IL-1b expression in moDCs
led us to characterize the interaction between GM-CSF and IL-1
during EAE pathogenesis. We immunized IL-1R-deficient mice
and analyzed the quality of inflammation in the SLNs and CNS.
As previously described (Lukens et al., 2012), Il1r/ mice were
resistant to EAE (Figure S6A). Our data show that GM-CSF-ex-
pressing Th cell subsets are not generated in the SLN after im-508 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.munization (Figure S6B). Given this profound defect, Il1r/
mice fail to develop CNS inflammation (Figure S6C). To study
the interdependence of moDC-derived IL-1 and T-cell-derived
GM-CSF within an inflamed CNS, we generated EAE-suscepti-
ble mixed BM chimeras. Chimeric mice bearing both Csf2rb+/+
(CD45.1) and Csf2rbLacZ/LacZ (CD45.2) hematopoietic compart-
ments were generated. At the peak of disease, CNS-infiltrating
moDCs required a GM-CSF-mediated signal for optimal expres-
sion of IL-1a and IL-1b (Figures S6D and S6E). Chimeric mice
with mixed Il1r+/+ (CD45.1) and Il1r/ (CD45.2) BM were also
immunized and T cells were isolated from the CNS at the peak
of disease. We observed that GM-CSF-expressing pathogenic
T cells require IL-1R (Figures S6F and S6G). Therefore, our
data show that T-cell-derived GM-CSF acts on moDCs to
enhance IL-1 expression, which in turn drives the expansion of
GM-CSF-producing pathogenic T cells, leading to immune
amplification and a continuation of inflammation in the CNS.
The GM-CSF-Dependent Expression Signature
of CNS-Infiltrating moDCs
When all strains and myeloid cells analyzed in this report are
considered, onlyCcr2-creERT2+/+ Csf2rbfl/fl mice provided a suf-
ficient level of deletion in Ly6Chi monocytes and, by virtue of the
irreversibility of Cre-mediated recombination, in their progeny
(Figure S7). We asked whether GM-CSF directly controls the
wider inflammatory capacity of monocyte-derived inflammatory
cells in vivo. Csf2rb+/+:Csf2rbLacZ/LacZ mixed chimeras were
immunized and both Csf2rb+/+ and Csf2rbLacZ/LacZ moDCs infil-
trating the same inflamed CNS at the peak of disease were
FACS sorted and mRNA was extracted. Next generation
sequencing (NGS) was performed on these samples, and the
genome-wide expression profiles were obtained and compared
(Figures 6A and 6B). Of more than 22,000 genes expressed in
these cells, we identified 1,490 significantly altered expression
features between Csf2rb+/+ or Csf2rbLacZ/LacZ cells conforming
to a stringent significance threshold (p < 0.001). We confirmed
the absence of Csf2rb, whereas the Csf2ra expression was not
significantly altered. Furthermore, expression of GM-CSF-regu-
lated PPARg (encoded by Pparg), a molecule required for the
development and function of alveolar macrophages (Schneider
et al., 2014), was highly upregulated by GM-CSF (Figure 6C).
Further in-depth analysis of the GM-CSF-induced transcrip-
tome of tissue-infiltrating Csf2rbLacZ/LacZ moDCs revealed a
wide range of cellular mechanisms that were directly controlled
by GM-CSF signaling. Expression of CCL6, CCL17, and
CCL24 was strikingly reduced in moDCs lacking functional
GM-CSF receptors (Figure 6D). The interactions of these chemo-
kines with their receptors induce migration of phagocytic cells to
inflammatory foci and have been shown to be critical for the
development of EAE (Asensio et al., 1999; Forde et al., 2011;
Rottman et al., 2000). These data show that GM-CSF directly
modulates the expression of these chemoattractant proteins.
The CD137L/CD137 interaction has been shown to be critically
involved in development of EAE (Martı´nez Go´mez et al., 2012).
Although more classical costimulatory molecules including
CD40, CD86, and CD80 were not induced by GM-CSF, CD137
(4-1BB, Tnfrsf9) was dramatically upregulated by GM-CSF in tis-
sue-infiltrating moDCs.
Phagocytic moDCs in the CNS have been recently linked to
EAE progression (Yamasaki et al., 2014). Genes including
Mfge8, Cd1d1, Pld1, Scarb1, Clec7a, and Anxa1 are involved
in phagocytosis and require GM-CSF for optimal expression
(Figure 6D). Manipulating inflammasome function has also
been used successfully to dampen clinical EAE manifestations
(Bordon, 2012). More specifically, key components of the
NLRP3 inflammasome, namely ASC and NLRP3, play important
roles in EAE pathogenesis (Inoue et al., 2012), and IL-1 expres-
sion has been linked to blood brain barrier integrity (ArgawImet al., 2006).We selected genes linked to inflammasome function
and expression in tissue-infiltrating moDCs and assessed their
dependence on GM-CSF. In addition to the NLRP3 inflamma-
some, we assessed the GM-CSF-mediated regulation of genes
involved in NLRP1, IPAF, and AIM2 inflammasomes (Schroder
and Tschopp, 2010). We observed that Pycard, encoding ASC,
was significantly reduced in Csf2rbLacZ/LacZ moDCs (Figure 6D).
Thus, NLRP3 and AIM2 inflammasome function in moDCs is
directly regulated by GM-CSF due to their requirement for ASC
expression.
Collectively, GM-CSF is not required for the development of
inflammatory monocyte-derived cells, but it has a fundamental
impact on the capacity of these cells to coordinate tissue inflam-
mation by inducing multiple, defined cellular pathways required
for fulminant phagocytic function and proinflammatory re-
sponses. This dataset provides a full account of the transcrip-
tome of GM-CSF-activated myeloid cells, which infiltrate the
CNS and mediate tissue damage.
GM-CSF Regulates IL-1 Expression in Human
Monocytes
The importance of GM-CSF in CNS inflammatory disease has
recently also been translated to MS in humans (Hartmann
et al., 2014; Noster et al., 2014; Rasouli et al., 2015). More spe-
cifically, it has been shown that MS patients have increased fre-
quencies of GM-CSF-producing Th cells and this has been asso-
ciated with increased disease activity and severity (Hartmann
et al., 2014). To test whether our findings in EAE translate to
the human system, we examined whether GM-CSF elicits similar
pathogenic functions in human myeloid cells. For this purpose,
we used mass cytometry, an emerging technology for the study
of leukocyte subpopulations (Becher et al., 2014) and their cyto-
kine responsiveness (Bendall et al., 2011). We analyzed the GM-
CSF-induced response of whole human blood by examining the
breadth of STAT5 phosphorylation after stimulation. Consistent
with the respective populations in mice, we found that human
monocytes, as well as granulocytes (basophils, neutrophils),
strongly phosphorylated STAT5 in response to GM-CSF (Figures
7A and 7B). The obtained high-dimensional data were subjected
to unsupervised dimensionality reduction (t-SNE) to identify and
visualize the major leukocyte populations found in human pe-
ripheral blood (Figures 7C and 7D; Amir et al., 2013).
Next, we analyzed possible pathogenic mechanisms elicited
by GM-CSF downstream of STAT5 phosphorylation. Human pe-
ripheral blood mononucleated cells (PBMCs) stimulated with
GM-CSF showed a consistent upregulation of IL-1b expression
(Figure 7E). Taken together, our data indicate that also human
monocytes readily respond to GM-CSF by STAT5 phosphoryla-
tion and elicit a pathogenic program, which is characterized by
the expression of IL-1b.
DISCUSSION
T-cell-mediated chronic inflammatory autoimmune disorders
are initiated by dysregulated, autoantigen reactive Th cells. How-
ever, Th cells are not the major executers of tissue damage.
Myeloid cells accumulate in abundance at inflammatory foci
where they often represent the dominant cell type. We show
that GM-CSF directly links the disease-initiating capacity ofmunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc. 509
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Figure 6. Identification of the GM-CSF-Dependent Expression Signature in CNS-Infiltrating moDCs
(A) Cohorts of 7–10mixedBMchimericmice (CD45.2Csf2rbLacZ/LacZ: CD45.1Csf2rb+/+) were immunized. At the peak of disease,micewere sacrificed and pooled
and CNS-infiltrating moDCs were FACS sorted based on their expression of congenic CD45. One representative out of four independent FACS sorts is shown.
(B) Next generation sequencing (NGS) was performed onRNA extracted from sorted cells of four independent EAE immunizations andCNS harvests. 1,490 genes
are significantly altered to a minimum significance threshold of p < 0.001.
(C) Volcano plots showing the Log2 ratio versuslog10 p value (Csf2rb+/+/Csf2rbLacZ/LacZ). Normalized expression counts for the indicated genes (Csf2rb,Csf2ra,
and Pparg) are shown. Each data point (open circles, Csf2rb+/+; red circles, Csf2rbLacZ/LacZ) represents a pooled value from 7–10 chimeric animals.
(D) Heat maps showing GM-CSF-regulated genes, clustered to their indicated pathways. Significance is shown alongside. *p < 0.05, **p < 0.01, ***p < 0.001
(Student’s t test, unpaired).
Error bars represent ± SEM. See also Figure S6 and Accession Numbers.pathogenic Th cells with the inflammatory signature of mono-
cytes and their progeny. Since the initial observation that GM-
CSF-deficient mice were resistant to EAE (McQualter et al.,510 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.2001), numerous groups have investigated which responder
cells mediate this phenotype. By systematic analysis, we could
exclude a critical role for GM-CSF sensing in cDCs, neutrophils,
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Figure 7. Human Monocytes Phosphorylate STAT5 and Produce IL-1b in Response to GM-CSF Stimulation
(A) Annotated t-SNE map depicting the STAT5 phosphorylation (black to yellow gradient) upon GM-CSF stimulation in leukocyte populations from human whole
blood. GM-CSF-stimulated whole blood was stained with heavy-metal labeled antibodies and acquired on a mass cytometer. Data represent two experiments.
(B) Cumulative results of GM-CSF-induced pSTAT5 upregulation in human monocytes from four healthy individuals as shown overlayed in (A).
(C) Selected channels used in the t-SNE analysis to identify monocytes are overlayed as a color-coded z-dimension.
(D) Expression of all markers in the identified leukocyte populations (as seen in A) that were used for the t-SNE dimensionality reduction, plus the pSTAT5 staining
intensity of GM-CSF-stimulated samples (not used for t-SNE).
(E) Histogram and cumulative MFI of human PBMCs that were stimulated with or without 20 ng/ml GM-CSF or IFN-g for 6 hr in the presence of monensin and
analyzed for IL-1b production. Data represent two experiments with similar GM-CSF-induced upregulation of IL-1b observed.
Error bars represent ± SEM.andmicroglia. Instead, we identified Ly6ChiCCR2+monocytes to
be critically dependent on a specific signaling event that licenses
a pathogenic gene expression signature, which in turn initiates a
self-perpetuating inflammatory cascade within the tissue.
Our data confirm that cDCs respond readily to GM-CSF,
which translates to the regulation of several hundred genes
affecting survival and apoptosis (Kc et al., 2014). However,
the role of cDCs in EAE has been challenged (Becher and
Greter, 2012; Yogev et al., 2012). Moreover, Batf3/ mice,
which lack CD8+ and CD103+ DCs, are not EAE resistant (Edel-
son et al., 2011). Thus, despite an active response to GM-CSF
by cDCs, ablating GM-CSF responsiveness in these cells did
not result in EAE resistance. We show that moDCs accumulate
in the SLNs during early EAE. Our data suggest that GM-CSF-
driven moDCs play a non-redundant role during the generation
of pathogenic T cells through expression of polarizing cytokinesImsuch as IL-1b. A role for monocytes and monocyte-derived
cells in antigen presentation is now also beginning to emerge
(Jakubzick et al., 2013), suggesting that monocytes and their
progeny (largely MHC-II+) can perform functions traditionally
associated with cDCs. Their low expression of CD11c
compared to cDCs might indeed allow a significant proportion
of moDCs to escape traditional depletion systems using
CD11c-linked diphtheria toxin receptor, particularly if CD11c-
Cre is employed.
Neutrophils were also proposed to be essential in the patho-
genesis of EAE (Kroenke et al., 2010). However, deletion of the
GM-CSF signaling pathway in neutrophils (using the Lyz2-cre
Csf2rbfl/fl system) had no bearing on EAE progression. The
data here do not challenge the relative importance of neutrophils
per se, but exclude a critical role for GM-CSF for their pathoge-
nicity. Neutrophils are also a major GM-CSF-responsive cellmunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc. 511
type, with expression of genes involved in cell cycle, meta-
bolism, host defense, and apoptosis activated after GM-CSFR
engagement (Kobayashi et al., 2005). Despite both cell types be-
ing present in the inflamed CNS, the inflammatory signature
induced by GM-CSF in neutrophils is not essential for
neuroinflammation.
CNS-invading moDCs were recently found to mediate demy-
elination during EAE (Yamasaki et al., 2014). Ly6Chi monocytes
and their progeny are critical for preclinical autoimmunity using
Ccr2/mice or diverse depletion systems (Ko et al., 2014; Mild-
ner et al., 2009). We can conclude that GM-CSF plays no role in
the phenotypic transition ofmonocyte tomoDCs in terms of clas-
sical surface markers. During the course of the study, it proved
essential to delete Csf2rb in CCR2+Ly6Chi monocytes prior to
their differentiation to moDCs using the Ccr2-creERT2+/+
Csf2rbfl/fl mice. The susceptibility and progression of EAE in
Lyz2-cre Csf2rbfl/fl mice, despite largely efficient targeting of
CNS-infiltrating moDCs, showed that the critical signal sent to
monocytes by GM-CSF takes place prior to their terminal differ-
entiation. More than half of Ly6Chi monocytes in immunized
Lyz2-cre Csf2rbfl/fl mice retained their GM-CSF responsiveness,
representing a significant window after migration into an in-
flamed site during which GM-CSF can initiate an inflammatory
signature.
Among the GM-CSF-induced genes expressed by moDCs in
the inflamed CNS, CCL6, CCL24, and CCL17 are also known
to be critical for EAE development (Asensio et al., 1999; Forde
et al., 2011; Rottman et al., 2000). Interestingly, their collective
primary function is to recruit more myeloid cells into the inflam-
matory foci, highlighting a GM-CSF-driven immune amplification
during neuroinflammation. Once arriving in the inflamed CNS,
GM-CSF sustains the expression of the adaptor protein ASC in
moDCs. Given that IL-1 expression is known to modulate blood
brain barrier integrity (Argaw et al., 2006), a functional inflamma-
some resulting in elevated, mature IL-1 within the CNS would
contribute significantly to EAE progression. The role for IL-1 in
the generation of Th17 cells during EAE has been proposed pre-
viously (Chung et al., 2009), and we add to this observation by
highlighting the role of IL-1R for optimal GM-CSF expression
by encephalitogenic Th cells in the inflamed brain. Therefore,
therapeutic interventions aimed at targeting GM-CSF during
inflammation will restrict not only the inflammatory myeloid
responder cells but also the autoaggressive T cells providing
GM-CSF.
The intention of this report is to bring consensus to the autoim-
munity field and provide unambiguous evidence as to where and
why GM-CSF has such an impact in tissue damage, and which
cell types require a GM-CSF signaling event to mediate inflam-
mation. Autoaggressive, pathogenic T cells license an inflamma-
tory program in monocytes through GM-CSF, which become
pathogenic moDCs. This cell population is in fact themost abun-
dant cellular infiltrate in neuroinflammation and the best equip-
ped to cause the tissue damage and demyelination observed
in EAE. In addition to potential therapeutic benefits of targeting
GM-CSF directly, a selection of GM-CSF-induced pathological
mechanisms within tissue-destructive myeloid cells are outlined
in this study. As such, not only GM-CSF itself, but also down-
stream effector proteins, are potentially open to inhibitory
interventions.512 Immunity 43, 502–514, September 15, 2015 ª2015 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice
To generate Csf2rbLacZ mice, targeted JM8.A3 embryonic stem cells were ob-
tained from EUCOMM (Csf2rbtm1a(EUCOMM)Hmgu; IKMC project: 80282). The
L1L2_Bact_P cassette was placed upstream of exon 4. Usage of the EN2
(engrailed 2) splice acceptor results in a fusionmessage between the first three
exons and the LacZ reporter sequence, resulting in a truncated Csf2rb mes-
sage. Mice were further crossed to a flp-deleter strain, resulting in a LoxP-
flanked exon 4 of Csf2rb, allowing for Cre-mediated conditional gene deletion.
Primers forCsf2rbfl PCRwere as follows: forward, 50-GAG AGAGGG TCC TTT
TGG TC-30; reverse, 50-CCT CCCCTC TTC TGT ATC TTC-30. Band size for WT
was 297 bp; for Csf2rbfl, 350 bp. Primers for Csf2rbLacZ PCR (P1 and P2 =WT;
P1 and P3= LacZ)were as follows: P1, 50-ACCACCACCAGCATCCAA TC-30;
P2, 50-CCC TCT TCT GTA TCT TCG CC-30; P3, 50-CAC TGA GTC TCT GGC
ATC TC-30.
The Ccr2-creERT2 mKate2 strain was generated upon request by Taconi-
cArtermis (PCR: forward, 50-CTC TAC TTC ATC GCA TTC CTT GC-30; reverse,
50-GGT TGA TGA AGG TTT TGC TGC-30; band size = 341 bp). Lyz2-cre and
Cd207-cre mice were provided by Bjo¨rn Clausen. Itgax-cre mice were pro-
vided by Boris Reizis. Il1r/ mice have been previously described (Glaccum
et al., 1997), as have TdTomato reporter mice (Madisen et al., 2010) and
Csf2rb/ mice (Robb et al., 1995). All cre strains were heterozygous unless
otherwise indicated. All animal experiments performed in this study were
approved by the Cantonal Veterinary Office Zurich.
EAE, Tamoxifen Treatment, and Bone Marrow Chimeras
EAE was induced and clinically scored as previously described (Codarri et al.,
2011). Tamoxifen (Sigma) was dissolved in ethanol and corn oil to 25 mg/ml
and administered in 200 ml doses via oral gavage (5 mg/dose), or administered
via tamoxifen-containing food (Harlan). For generation of BM chimeras, host
animals received a split dose (23 550 Rad with 24 hr interval) before receiving
53 106 donor BM cells i.v. injected. 50:50 mixed chimeras received 2.53 106
cells from BM donors of each genotype.
Flow Cytometry and Mass Cytometry
More detailed information on flow cytometry (including antibody clones), intra-
cellular staining protocols, pSTAT phosphorylation/detection protocols, and
CyTOF data handling can be found in the Supplemental Experimental
Procedures.
Histopathological Analysis of EAE Tissue
LFB-PAS stainings were done according to standard protocols on 4% PFA-
fixed, paraffin-embedded, and 2-mm-thick tissue sections. We analyzed EAE
histopathology on cross-sections (four to six per mouse) of lumbar spinal
cords and recorded digital images of tissue sections with a Zeiss Axio Scan.Z1
Slide Scanner (Carl Zeiss, MicroImaging GmbH) with a 203 (air, NA 0.8) objec-
tive. Total demyelinated area of LFB- and PAS-stained sections wasmeasured
in mm2 by Fiji/ImageJ 1.46j software (NIH) and the area of demyelination calcu-
lated as percentage of the whole area of white matter within a given section.
Next Generation Sequencing
Chimeric mice were immunized and at peak diseases, moDCs were isolated
from brain and spinal cord as described above and FACS sorted (BD
FACSAria III). Total RNA from a minimum of 5 3 105 up to 1.2 3 106 cells
was isolated with QIAGEN RNeasy Plus Micro Kit according to manufacturer’s
instructions resulting in RINR 8. NGSwas performed by the Functional Geno-
mics Center Zurich (http://www.fgcz.ch).
Statistical Analysis
Mean values, SEM values, and Student’s t test (unpaired) were calculated with
Prism (GraphPad software). *p < 0.05, **p < 0.01, ***p < 0.001. Significance for
pooled EAE experiments was performed by two-way ANOVA analysis.
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Sequencing information is available at the European Bioinformatics Institute
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